RxDoctor Payments Data

John Barnes, MD

Family Medicine · Vicksburg, MSNPI 1205865680

Payments from drug & device makers

$1,646in general payments, 2019–2025

Across 110 payments — averaging $14.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$410
  • Amgen$214
  • Johnson & Johnson$193
  • GSK$96
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$84
  • Bayer$82
  • plus $567 from 18 others

What the payments were for

  • Food & beverage$1,63299%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,646 in reported general payments places this provider in the 65th percentile of 971 family medicine providers in Mississippi.

See all family medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$85,802
Medicare patients
153
Services billed
945

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin230$101,427
JulucaDolutegravir/Rilpivirine13$44,500
EliquisApixaban98$44,151
OzempicSemaglutide43$44,107
XareltoRivaroxaban77$40,127
FarxigaDapagliflozin Propanediol42$22,093
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$18,364
EntrestoSacubitril/Valsartan27$16,927
Lacosamide40$13,485
Levetiracetam241$12,905
BrilintaTicagrelor42$11,562
JanuviaSitagliptin Phosphate26$10,687
Potassium Chloride325$9,436
Rivastigmine30$9,304
SantylCollagenase Clostridium Hist.23$7,293

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$73$101,427230 claims
Novo NordiskOzempic, Levemir, Novolog, Fiasp$410$54,692127 claims
Johnson & JohnsonXarelto, Invokana$193$45,26991 claims
PfizerEliquis$24$44,15198 claims
AstraZenecaFarxiga, Brilinta, Symbicort$42$39,291107 claims
GSKTrelegy Ellipta$96$18,36429 claims
AbbVieCreon, Lumigan$28$13,80248 claims
MerckJanuvia$70$10,68726 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 971 family medicine providers in Mississippi.

Other family medicine in Vicksburg

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →